Elsevier Inc.

SHERPA: Unknown

People

  1. Shen
    Shen
  2. Arcila
    Arcila
  3. Offin
    Offin
  4. Rudin
    Rudin
  5. Kris
    Kris
  6. Li
    Li
  7. Riely
    Riely
  8. Yu
    Yu
  9. Ladanyi
    Ladanyi
  10. Rekhtman
    Rekhtman

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  2. Biostatistics Service (6)
  3. Department of Medicine (6)
  4. Epidemiology and Biostatistics (6)
  5. GSK Faculty (6)
  6. Population Sciences Research Program (6)
  7. Solid Tumor Oncology Division (6)
  8. Thoracic Oncology (6)
  9. Body Imaging Service (2)
  10. Human Oncology and Pathogenesis Program (2)
Search Within
  1. "Charles Rudin"
  2. "Ronglai Shen"
  3. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  2. Biostatistics Service (6)
  3. Department of Medicine (6)
  4. Epidemiology and Biostatistics (6)
  5. GSK Faculty (6)
  6. Population Sciences Research Program (6)

More Groups

People
  1. Charles Rudin (6)
  2. Ronglai Shen (6)
  3. Maria Arcila (5)
  4. Michael Offin (5)
  5. Bob Li (3)
  6. Gregory Riely (3)

More People

Years
  1. 2019 (1)
  2. 2018 (5)
Publications
  1. Journal of Thoracic Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Detecting HER2 alterations by next generation sequencing (NGS) in patients with advanced NSCLC from the United States and China
    Meeting Abstract

    Xu, C.; Zhang, Y.; Liu, D.; Shen, R.; Razavi, P.; Liu, S.; Sun, H.; Offin, M.; Drilon, A.; Rudin, C.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial
    Meeting Abstract

    Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Utility of cfDNA testing for acquired resistance: The Memorial Sloan Kettering experience with plasma EGFR T790M clinical testing
    Meeting Abstract

    Offin, M.; Myers, M.; Josyula, S.; Shen, R.; Borsu, L.; Tsui, D.; Riely, G.; Rudin, C.; Yu, H.; Li, B.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of EGFR mutant lung cancers with concurrent TP53 and RB1 mutations
    Meeting Abstract

    Offin, M.; Tenet, M.; Shen, R.; Rekhtman, N.; Rizvi, H.; Hellmann, M.; Arcila, M.; Ladanyi, M.; Rudin, C.; Kris, M.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save